MS-Based Approaches for Studying The Pharmacokinetics of Protein Drugs
Authors:
- 9 March 2011
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 3 (5) , 477-480
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Characterization of protein therapeutics by mass spectrometry: recent developments and future directionsDrug Discovery Today, 2011
- Targeted ion parking for the quantitation of biotherapeutic proteins: Concepts and preliminary dataJournal of the American Society for Mass Spectrometry, 2010
- Combined use of immunoassay and two-dimensional liquid chromatography mass spectrometry for the detection and identification of metabolites from biotherapeutic pharmacokinetic samplesJournal of Pharmaceutical and Biomedical Analysis, 2010
- Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasmaRapid Communications in Mass Spectrometry, 2010
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometryJournal of Immunological Methods, 2009
- Bioanalysis of recombinant proteins and antibodies by mass spectrometryThe Analyst, 2009
- Protein Standard Absolute Quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaksProteomics, 2008
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometryJournal of Chromatography B, 2008
- Quantitative aspects of the analysis of the monoclonal antibody trastuzumab using high-performance liquid chromatography coupled with electrospray mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2008